![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SPAG7 |
Gene summary for SPAG7 |
![]() |
Gene information | Species | Human | Gene symbol | SPAG7 | Gene ID | 9552 |
Gene name | sperm associated antigen 7 | |
Gene Alias | ACRP | |
Cytomap | 17p13.2 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | O75391 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9552 | SPAG7 | HTA11_3410_2000001011 | Human | Colorectum | AD | 2.45e-04 | 9.13e-02 | 0.0155 |
9552 | SPAG7 | HTA11_2487_2000001011 | Human | Colorectum | SER | 7.61e-08 | 3.63e-01 | -0.1808 |
9552 | SPAG7 | HTA11_2951_2000001011 | Human | Colorectum | AD | 4.37e-02 | 3.73e-01 | 0.0216 |
9552 | SPAG7 | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.33e-04 | 3.19e-01 | -0.0811 |
9552 | SPAG7 | HTA11_347_2000001011 | Human | Colorectum | AD | 1.59e-10 | 3.30e-01 | -0.1954 |
9552 | SPAG7 | HTA11_411_2000001011 | Human | Colorectum | SER | 3.80e-08 | 6.26e-01 | -0.2602 |
9552 | SPAG7 | HTA11_3361_2000001011 | Human | Colorectum | AD | 8.45e-07 | 4.00e-01 | -0.1207 |
9552 | SPAG7 | HTA11_83_2000001011 | Human | Colorectum | SER | 3.24e-04 | 3.73e-01 | -0.1526 |
9552 | SPAG7 | HTA11_696_2000001011 | Human | Colorectum | AD | 2.60e-14 | 4.25e-01 | -0.1464 |
9552 | SPAG7 | HTA11_866_2000001011 | Human | Colorectum | AD | 6.23e-09 | 3.30e-01 | -0.1001 |
9552 | SPAG7 | HTA11_1391_2000001011 | Human | Colorectum | AD | 7.41e-18 | 5.42e-01 | -0.059 |
9552 | SPAG7 | HTA11_2992_2000001011 | Human | Colorectum | SER | 5.76e-05 | 4.73e-01 | -0.1706 |
9552 | SPAG7 | HTA11_5212_2000001011 | Human | Colorectum | AD | 3.74e-04 | 4.22e-01 | -0.2061 |
9552 | SPAG7 | HTA11_546_2000001011 | Human | Colorectum | AD | 1.88e-04 | 3.23e-01 | -0.0842 |
9552 | SPAG7 | HTA11_7862_2000001011 | Human | Colorectum | AD | 7.34e-05 | 4.05e-01 | -0.0179 |
9552 | SPAG7 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.99e-14 | 4.49e-01 | 0.096 |
9552 | SPAG7 | HTA11_8622_2000001021 | Human | Colorectum | SER | 7.47e-07 | 3.29e-01 | 0.0528 |
9552 | SPAG7 | HTA11_7663_2000001011 | Human | Colorectum | SER | 1.83e-02 | 3.61e-01 | 0.0131 |
9552 | SPAG7 | HTA11_10623_2000001011 | Human | Colorectum | AD | 9.35e-08 | 4.55e-01 | -0.0177 |
9552 | SPAG7 | HTA11_10711_2000001011 | Human | Colorectum | AD | 2.56e-04 | 2.95e-01 | 0.0338 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Oral cavity | OSCC | ![]() |
Oral cavity | LP | ![]() |
Oral cavity | EOLP | ![]() |
Oral cavity | NEOLP | ![]() |
Esophagus | HGIN | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SPAG7 | SNV | Missense_Mutation | c.664N>A | p.Glu222Lys | p.E222K | O75391 | protein_coding | tolerated(0.33) | benign(0.099) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
SPAG7 | SNV | Missense_Mutation | novel | c.231G>C | p.Glu77Asp | p.E77D | O75391 | protein_coding | tolerated(0.17) | benign(0.233) | TCGA-JW-A5VL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
SPAG7 | SNV | Missense_Mutation | c.429G>C | p.Gln143His | p.Q143H | O75391 | protein_coding | tolerated(0.1) | benign(0.254) | TCGA-JX-A3Q0-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unknown | Unknown | SD | |
SPAG7 | SNV | Missense_Mutation | c.145N>T | p.Arg49Cys | p.R49C | O75391 | protein_coding | deleterious(0) | possibly_damaging(0.877) | TCGA-EI-6917-01 | Colorectum | rectum adenocarcinoma | Male | <65 | III/IV | Chemotherapy | 5fluorouracil+oxaciplatina+l-folinian | SD | |
SPAG7 | SNV | Missense_Mutation | c.145N>T | p.Arg49Cys | p.R49C | O75391 | protein_coding | deleterious(0) | possibly_damaging(0.877) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SPAG7 | SNV | Missense_Mutation | rs377700806 | c.649N>T | p.Arg217Trp | p.R217W | O75391 | protein_coding | deleterious(0) | possibly_damaging(0.73) | TCGA-AX-A1C9-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SPAG7 | SNV | Missense_Mutation | novel | c.260N>C | p.Val87Ala | p.V87A | O75391 | protein_coding | deleterious(0.04) | benign(0.223) | TCGA-BK-A56F-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SPAG7 | SNV | Missense_Mutation | c.172G>A | p.Asp58Asn | p.D58N | O75391 | protein_coding | tolerated(0.38) | benign(0.005) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
SPAG7 | SNV | Missense_Mutation | c.134N>G | p.Lys45Arg | p.K45R | O75391 | protein_coding | tolerated(0.78) | benign(0.092) | TCGA-CC-5261-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
SPAG7 | SNV | Missense_Mutation | c.134N>G | p.Lys45Arg | p.K45R | O75391 | protein_coding | tolerated(0.78) | benign(0.092) | TCGA-DD-A11A-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |